Moderna, Inc

MRNANASDAQ · Biological Products, (No Diagnostic Substances)

Financing

SEC filings to 2026-10-05 · every row opens its filing

Shares on issue

399.0M

on 2026-06-30, from 383.0M on 2024-03-31 10-Q ↗

Newest

None

No S-3 or F-3 shelf on file in the last 30 months.

1 of its filings are not read yet.

Warrants

The 10-Q filed 2026-07-31 is not read yet.

Cash

19.2 quarters

$5.14B on 2026-06-30 ÷ $268.3M a quarter of operating cash used, the average of four quarters. 10-Q ↗

Raised: 2 of its filings are not read yet.

Also on file: $1K convertible notes, 2026-09-01 8-K ↗